S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

XOMAO XOMA Royalty Corporation

25.30

-0.06 (-0.24%)

Feb 04 2025 - Closed

Delayed by 15 minutes

Confidential Treatment Order (ct Order)

This regulatory filing also includes additional resources:
filename1.pdf

XOMA Royalty (NASDAQ:XOMAO)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more XOMA Royalty Charts.

XOMA Royalty (NASDAQ:XOMAO)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more XOMA Royalty Charts.

Xoma Corp News

XOMA Royalty to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference
Tuesday 4 February 2025 (16 hours ago) • GlobeNewswire Inc.

XOMA Royalty Declares Quarterly Preferred Stock Dividends
Thursday 19 December 2024 (2 months ago) • GlobeNewswire Inc.

XOMA Royalty Acquires Pulmokine for $20 Million Adding the Royalty and Milestone Interest in Seralutinib, a Phase 3 Asset, to Its Portfolio
Monday 2 December 2024 (2 months ago) • GlobeNewswire Inc.

XOMA Royalty Reports Third Quarter 2024 Financial Results and Highlights Recent Activities
Thursday 7 November 2024 (3 months ago) • GlobeNewswire Inc.

XOMA Royalty Significantly Expands its Royalty and Milestone Portfolio with the Addition of Over 60 Early-Stage Programs from Twist Bioscience
Tuesday 22 October 2024 (3 months ago) • GlobeNewswire Inc.

Zevra’s MIPLYFFA™ (arimoclomol) Receives Approval from U.S. Food and Drug Administration for Use in Patients with Niemann-Pick Disease Type C (NPC)
Monday 23 September 2024 (4 months ago) • GlobeNewswire Inc.

XOMA Royalty Declares Quarterly Preferred Stock Dividends
Monday 23 September 2024 (4 months ago) • GlobeNewswire Inc.

XOMA Royalty to Present at Upcoming Investor Conferences in September
Wednesday 4 September 2024 (5 months ago) • GlobeNewswire Inc.

XOMA Royalty Reports Second Quarter 2024 Financial Results and Highlights Recent Activities
Tuesday 13 August 2024 (6 months ago) • GlobeNewswire Inc.

XOMA Declares Quarterly Preferred Stock Dividends
Thursday 20 June 2024 (8 months ago) • GlobeNewswire Inc.

XOMA Receives $8.1 Million Milestone Related to Day One Biopharmaceuticals’ Sale of its Priority Review Voucher
Wednesday 12 June 2024 (8 months ago) • GlobeNewswire Inc.

XOMA to Present at H.C. Wainwright 2nd Annual Bioconnect Investor Conference at NASDAQ
Tuesday 14 May 2024 (9 months ago) • GlobeNewswire Inc.

More Xoma Corp News Articles

Asia Broadband (PK)

Accredited Solutions (PK)

TheGlobe com (PK)

Lightwave Logic

RespireRx Pharmaceuticals (CE)

Greene Concepts (PK)

Fannie Mae (QB)

Intergrated Cannabis Sol... (PK)

NioCorp Developments

Brookmount Explorations (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions